Annual Total Assets
$339.89 M
+$78.05 M+29.81%
December 31, 2023
Summary
- As of February 27, 2025, FDMT annual total assets is $339.89 million, with the most recent change of +$78.05 million (+29.81%) on December 31, 2023.
- During the last 3 years, FDMT annual total assets has risen by +$51.56 million (+17.88%).
- FDMT annual total assets is now -3.85% below its all-time high of $353.49 million, reached on December 31, 2021.
Performance
FDMT Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Assets
$604.03 M
-$16.09 M-2.59%
September 30, 2024
Summary
- As of February 27, 2025, FDMT quarterly total assets is $604.03 million, with the most recent change of -$16.09 million (-2.59%) on September 30, 2024.
- Over the past year, FDMT quarterly total assets has increased by +$242.41 million (+67.04%).
- FDMT quarterly total assets is now -4.10% below its all-time high of $629.88 million, reached on March 31, 2024.
Performance
FDMT Quarterly Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Assets Formula
Total Assets = Current Assets + Non-Current Assets
FDMT Total Assets Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +29.8% | +67.0% |
3 y3 years | +17.9% | +67.0% |
5 y5 years | +250.5% | +67.0% |
FDMT Total Assets Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -3.9% | +29.8% | -4.1% | +147.5% |
5 y | 5-year | -3.9% | +483.7% | -4.1% | +937.2% |
alltime | all time | -3.9% | +1144.1% | -4.1% | +937.2% |
4D Molecular Therapeutics Total Assets History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $604.03 M(-2.6%) |
Jun 2024 | - | $620.12 M(-1.6%) |
Mar 2024 | - | $629.88 M(+85.3%) |
Dec 2023 | $339.89 M(+29.8%) | $339.89 M(-6.0%) |
Sep 2023 | - | $361.61 M(+2.6%) |
Jun 2023 | - | $352.50 M(+44.5%) |
Mar 2023 | - | $244.02 M(-6.8%) |
Dec 2022 | $261.85 M | $261.85 M(-6.5%) |
Sep 2022 | - | $280.16 M(-7.5%) |
Jun 2022 | - | $302.94 M(-6.8%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2022 | - | $324.93 M(-8.1%) |
Dec 2021 | $353.49 M(+22.6%) | $353.49 M(+46.9%) |
Sep 2021 | - | $240.62 M(-5.6%) |
Jun 2021 | - | $254.93 M(-5.6%) |
Mar 2021 | - | $270.11 M(-6.3%) |
Dec 2020 | $288.33 M(+395.1%) | $288.33 M(+193.6%) |
Sep 2020 | - | $98.19 M(+68.6%) |
Dec 2019 | $58.23 M(-39.9%) | $58.23 M(-27.7%) |
Jun 2019 | - | $80.50 M(-17.0%) |
Dec 2018 | $96.97 M(+254.9%) | $96.97 M |
Dec 2017 | $27.32 M | - |
FAQ
- What is 4D Molecular Therapeutics annual total assets?
- What is the all time high annual total assets for 4D Molecular Therapeutics?
- What is 4D Molecular Therapeutics annual total assets year-on-year change?
- What is 4D Molecular Therapeutics quarterly total assets?
- What is the all time high quarterly total assets for 4D Molecular Therapeutics?
- What is 4D Molecular Therapeutics quarterly total assets year-on-year change?
What is 4D Molecular Therapeutics annual total assets?
The current annual total assets of FDMT is $339.89 M
What is the all time high annual total assets for 4D Molecular Therapeutics?
4D Molecular Therapeutics all-time high annual total assets is $353.49 M
What is 4D Molecular Therapeutics annual total assets year-on-year change?
Over the past year, FDMT annual total assets has changed by +$78.05 M (+29.81%)
What is 4D Molecular Therapeutics quarterly total assets?
The current quarterly total assets of FDMT is $604.03 M
What is the all time high quarterly total assets for 4D Molecular Therapeutics?
4D Molecular Therapeutics all-time high quarterly total assets is $629.88 M
What is 4D Molecular Therapeutics quarterly total assets year-on-year change?
Over the past year, FDMT quarterly total assets has changed by +$242.41 M (+67.04%)